HOME >> BIOLOGY >> NEWS
Calcium may protect women from cancer

A University of Minnesota Cancer Center study found that women consuming more than 800 milligrams of calcium each day reduced their risk of colorectal cancer by as much as 26 to 46 percent. A 26 percent reduction in risk of colorectal cancer occurred regardless of whether the calcium intake was from diet or supplement. Among women who consumed high levels of calcium from both diet and supplements, the risk reduction was almost double that observed for calcium from either source by itself.

The results of the study appear in this month's Cancer Epidemiology, Biomarkers and Prevention journal. Andrew Flood, Ph.D., epidemiologist with the University of Minnesota Cancer Center and School of Public Health, led the study in collaboration with the National Cancer Institute (NCI).

The study involved 45,354 women in the United States who did not have a history of colorectal cancer. The women were categorized into groups according to information they provided about their diets and lifestyles. The women averaged 61.9 years of age upon entering the study and they were followed in the study for an average of 8.5 years. This study began in 1987 and closed in 1997. During that time, 482 women in the study developed colorectal cancer.

"It is especially notable that the risk reduction was present regardless of the source of the calcium, and that simultaneously consuming high levels of calcium from both diet and supplements further reduced risk," Flood said. "These observations suggest that it was the calcium per se, and not merely dairy products or some other variable that accounted for the reduction in risk."

The findings provide further evidence in a growing body of research that indicates a link between calcium and prevention of colorectal cancer. This study is good news for women because they comprise about half of the approximately 150,000 people in the United States diagnosed annually with colorectal cancer. The cancer ranks as the second leading cause of
'"/>

Contact: Mary Lawson
mlawson@umn.edu
612-624-6165
University of Minnesota
27-Jan-2005


Page: 1 2 3

Related biology news :

1. Calcium important for nursing mothers oral health
2. Calcium and vitamin D supplements offer modest bone improvements, no benefits for colorectal cancer
3. A treatment, not a cure: Calcium silicate neutralizes an acidic stream
4. Multinational research: protecting ecology means understanding people, too
5. No evidence that widely prescribed statins protect against prostate cancer
6. Rain forest protection works in Peru
7. New study suggests Concord grape juice may provide protection against breast cancer
8. Innovative tagging technique may help researchers better protect fish stocks
9. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
10. Reading ability protects brain from lead exposure
11. Research shows NPD1 protects a key component of vision

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Calcium may protect women from cancer

(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) ... about the impact of coffee on autoimmune disease and ... consumption recently has been associated with reduced risk of ... more cups of java each month also correlate with ... at the Mayo Clinic, Rochester, MN, linked coffee consumption ...
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Smarter ... outdoor security solutions, today announced that Genzyme, a Sanofi ... units of Door Detective® CL for a multi-use facility ... installed in four other Genzyme buildings, this latest order ... with the tailgate detection device improving doorway ...
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
(Date:5/21/2013)... 2013 PathoGenetix, Inc., a commercial-stage developer ... announced today that it has successfully identified and strain ... obtained from the Centers for Disease Control and Prevention ... The findings are detailed in a poster ... for Microbiology in Denver on Monday. , The 250 ...
Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
Cached News: